Published in Proteomics on September 01, 2003
Two-dimensional southwestern blotting and characterization of transcription factors on-blot. J Proteome Res (2009) 1.25
Systems-wide temporal proteomic profiling in glucose-starved Bacillus subtilis. Nat Commun (2010) 1.19
Polar positioning of a conjugation protein from the integrative and conjugative element ICEBs1 of Bacillus subtilis. J Bacteriol (2010) 1.11
Use of nitrocellulose membranes for protein characterization by matrix-assisted laser desorption/ionization mass spectrometry. Anal Chem (2006) 1.09
Analysis of electroblotted proteins by mass spectrometry: protein identification after Western blotting. Mol Cell Proteomics (2007) 0.95
Bacterial pleckstrin homology domains: a prokaryotic origin for the PH domain. J Mol Biol (2009) 0.85
On-membrane tryptic digestion of proteins for mass spectrometry analysis. Methods Mol Biol (2009) 0.81
Centrifugal methods and devices for rapid in-gel digestion of proteins. Electrophoresis (2009) 0.80
Sample preparation for the analysis of membrane proteomes by mass spectrometry. Protein Cell (2012) 0.75
Analysis of Electroblotted Proteins by Mass Spectrometry. Methods Mol Biol (2015) 0.75
Protein extraction and 2-DE of water- and lipid-soluble proteins from bovine pericardium, a low-cellularity tissue. Electrophoresis (2008) 0.75
Alternative O-GlcNAcylation/O-phosphorylation of Ser16 induce different conformational disturbances to the N terminus of murine estrogen receptor beta. Chem Biol (2006) 1.74
Phosphatidylserine-containing liposomes inhibit the differentiation of osteoclasts and trabecular bone loss. J Immunol (2010) 1.45
Functional analysis of Arabidopsis thaliana RHM2/MUM4, a multidomain protein involved in UDP-D-glucose to UDP-L-rhamnose conversion. J Biol Chem (2006) 1.40
Long-range interaction and correlation between MYC enhancer and oncogenic long noncoding RNA CARLo-5. Proc Natl Acad Sci U S A (2014) 1.39
Identification and characterization of novel small RNAs in the aspS-yrvM intergenic region of the Bacillus subtilis genome. Microbiology (2002) 1.30
Bacillus minimum genome factory: effective utilization of microbial genome information. Biotechnol Appl Biochem (2007) 1.25
Involvement of two different cell death pathways in retinal atrophy of cathepsin D-deficient mice. Mol Cell Neurosci (2003) 1.21
Expression of a small RNA, BS203 RNA, from the yocI-yocJ intergenic region of Bacillus subtilis genome. FEMS Microbiol Lett (2002) 1.19
Two novel mutations in the EYS gene are possible major causes of autosomal recessive retinitis pigmentosa in the Japanese population. PLoS One (2012) 1.17
MicroRNA-31 predicts the presence of lymph node metastases and survival in patients with lung adenocarcinoma. Clin Cancer Res (2013) 1.17
Tryptase inhibition blocks airway inflammation in a mouse asthma model. J Immunol (2002) 1.16
Reverse of age-dependent memory impairment and mitochondrial DNA damage in microglia by an overexpression of human mitochondrial transcription factor a in mice. J Neurosci (2008) 1.15
Proteases involved in long-term potentiation. Life Sci (2002) 1.13
Molecular cloning and characterization of a novel UDP-GlcNAc:GalNAc-peptide beta1,3-N-acetylglucosaminyltransferase (beta 3Gn-T6), an enzyme synthesizing the core 3 structure of O-glycans. J Biol Chem (2002) 1.10
Microglial Ca(2+)-activated K(+) channels are possible molecular targets for the analgesic effects of S-ketamine on neuropathic pain. J Neurosci (2011) 1.04
Molecular cloning and characterization of a novel human beta 1,4-N-acetylgalactosaminyltransferase, beta 4GalNAc-T3, responsible for the synthesis of N,N'-diacetyllactosediamine, galNAc beta 1-4GlcNAc. J Biol Chem (2003) 0.99
Bacillus subtilis LmrA is a repressor of the lmrAB and yxaGH operons: identification of its binding site and functional analysis of lmrB and yxaGH. J Bacteriol (2004) 0.97
A case of very large intrahepatic bile duct adenoma followed for 7 years. World J Clin Oncol (2012) 0.96
Effectiveness and limitation of two-dimensional gel electrophoresis in bacterial membrane protein proteomics and perspectives. J Chromatogr B Analyt Technol Biomed Life Sci (2005) 0.96
Acute p38-mediated inhibition of NMDA-induced outward currents in hippocampal CA1 neurons by interleukin-1beta. Neurobiol Dis (2010) 0.94
Involvement of cathepsin B in the processing and secretion of interleukin-1beta in chromogranin A-stimulated microglia. Glia (2010) 0.94
Age-dependent responses of glial cells and leptomeninges during systemic inflammation. Neurobiol Dis (2008) 0.92
Biochemical and crystallographic analyses of maltohexaose-producing amylase from alkalophilic Bacillus sp. 707. Biochemistry (2004) 0.92
Leptomeningeal cells activate microglia and astrocytes to induce IL-10 production by releasing pro-inflammatory cytokines during systemic inflammation. J Neuroimmunol (2005) 0.92
Mannitol-1-phosphate dehydrogenase (MtlD) is required for mannitol and glucitol assimilation in Bacillus subtilis: possible cooperation of mtl and gut operons. J Bacteriol (2003) 0.92
A novel human beta1,3-N-acetylgalactosaminyltransferase that synthesizes a unique carbohydrate structure, GalNAcbeta1-3GlcNAc. J Biol Chem (2004) 0.91
Binding of copper (II) ion to an Alzheimer's tau peptide as revealed by MALDI-TOF MS, CD, and NMR. Biopolymers (2005) 0.91
Involvement of COX-1 and up-regulated prostaglandin E synthases in phosphatidylserine liposome-induced prostaglandin E2 production by microglia. J Neuroimmunol (2005) 0.91
Potentiation of the NMDA receptor-mediated responses through the activation of the glycine site by microglia secreting soluble factors. Glia (2006) 0.90
Enhancement of N-methyl- D-aspartate receptor-mediated excitatory postsynaptic potentials in the neostriatum after methamphetamine sensitization. An in vitro slice study. Exp Brain Res (2002) 0.89
Multidrug resistant phenotype of Bacillus subtilis spontaneous mutants isolated in the presence of puromycin and lincomycin. Can J Microbiol (2003) 0.89
Copper binding properties of a tau peptide associated with Alzheimer's disease studied by CD, NMR, and MALDI-TOF MS. Peptides (2005) 0.88
Profiling and comprehensive expression analysis of ABC transporter solute-binding proteins of Bacillus subtilis membrane based on a proteomic approach. Electrophoresis (2004) 0.88
Lincomycin resistance mutations in two regions immediately downstream of the -10 region of lmr promoter cause overexpression of a putative multidrug efflux pump in Bacillus subtilis mutants. Antimicrob Agents Chemother (2003) 0.88
Amyloid-beta fibril formation is not necessarily required for microglial activation by the peptides. Neurochem Int (2005) 0.87
Involvement of cathepsin E in exogenous antigen processing in primary cultured murine microglia. J Biol Chem (2001) 0.87
Inhibition of NMDA-induced outward currents by interleukin-1beta in hippocampal neurons. Biochem Biophys Res Commun (2008) 0.87
Molecular cloning and characterization of beta1,4-N-acetylgalactosaminyltransferases IV synthesizing N,N'-diacetyllactosediamine. FEBS Lett (2004) 0.86
Microglial cathepsin B contributes to the initiation of peripheral inflammation-induced chronic pain. J Neurosci (2012) 0.86
Cathepsin B-dependent motor neuron death after nerve injury in the adult mouse. Biochem Biophys Res Commun (2010) 0.85
Phosphatidylserine-containing liposomes suppress inflammatory bone loss by ameliorating the cytokine imbalance provoked by infiltrated macrophages. Lab Invest (2011) 0.85
Effect of Bacillus subtilis spo0A mutation on cell wall lytic enzymes and extracellular proteases, and prevention of cell lysis. J Biosci Bioeng (2007) 0.85
Differential pathways for interleukin-1β production activated by chromogranin A and amyloid β in microglia. Neurobiol Aging (2013) 0.83
Phosphatidylserine and phosphatidylcholine-containing liposomes inhibit amyloid beta and interferon-gamma-induced microglial activation. Free Radic Biol Med (2006) 0.83
How does prolonged caloric restriction ameliorate age-related impairment of long-term potentiation in the hippocampus? Brain Res Mol Brain Res (2003) 0.83
An Usher syndrome type 1 patient diagnosed before the appearance of visual symptoms by MYO7A mutation analysis. Int J Pediatr Otorhinolaryngol (2012) 0.82
Reduced synaptic activity precedes synaptic stripping in vagal motoneurons after axotomy. Glia (2008) 0.82
The design and synthesis of novel alpha-ketoamide-based p38 MAP kinase inhibitors. Bioorg Med Chem Lett (2008) 0.82
Possible involvement of cathepsin B released by microglia in methylmercury-induced cerebellar pathological changes in the adult rat. Neurosci Lett (2008) 0.82
NMR and CD studies on the interaction of Alzheimer beta-amyloid peptide (12-28) with beta-cyclodextrin. Biochem Biophys Res Commun (2002) 0.81
Effects of essential carbohydrate/aromatic stacking interaction with Tyr100 and Phe259 on substrate binding of cyclodextrin glycosyltransferase from alkalophilic Bacillus sp. 1011. J Biochem (2003) 0.81
The intrinsic microglial molecular clock controls synaptic strength via the circadian expression of cathepsin S. Sci Rep (2013) 0.81
Cell cycle-dependent regulation of kainate-induced inward currents in microglia. Biochem Biophys Res Commun (2006) 0.81
Involvement of lysosomal storage-induced p38 MAP kinase activation in the overproduction of nitric oxide by microglia in cathepsin D-deficient mice. Mol Cell Neurosci (2007) 0.81
Bacillus subtilis AprX involved in degradation of a heterologous protein during the late stationary growth phase. J Biosci Bioeng (2007) 0.81
Copper (II) modulates in vitro aggregation of a tau peptide. Peptides (2007) 0.81
Impairment of microglial responses to facial nerve axotomy in cathepsin S-deficient mice. J Neurosci Res (2007) 0.81
Impact of diabetes on the outcomes of cervical laminoplasty: a prospective cohort study of more than 500 patients with cervical spondylotic myelopathy. Spine (Phila Pa 1976) (2014) 0.81
Peripheral role of cathepsin S in Th1 cell-dependent transition of nerve injury-induced acute pain to a chronic pain state. J Neurosci (2014) 0.80
Potentiation of NMDA receptor-mediated synaptic responses by microglia. Brain Res Mol Brain Res (2003) 0.80
Brazilian green propolis suppresses the hypoxia-induced neuroinflammatory responses by inhibiting NF-κB activation in microglia. Oxid Med Cell Longev (2013) 0.80
Identification and characterization of the Bacillus subtilis D-glucarate/galactarate utilization operon ycbCDEFGHJ. FEMS Microbiol Lett (2002) 0.80
Optimization of alpha-ketoamide based p38 inhibitors through modifications to the region that binds to the allosteric site. Bioorg Med Chem Lett (2010) 0.80
Connection between periodontitis and Alzheimer's disease: possible roles of microglia and leptomeningeal cells. J Pharmacol Sci (2014) 0.80
Surgical Treatment Assessment of Cervical Laminoplasty Using Quantitative Performance Evaluation in Elderly Patients: A Prospective Comparative Study in 505 Patients With Cervical Spondylotic Myelopathy. Spine (Phila Pa 1976) (2016) 0.79
Involvement of prostaglandin E2 released from leptomeningeal cells in increased expression of transforming growth factor-beta in glial cells and cortical neurons during systemic inflammation. J Neurosci Res (2007) 0.79
Down-regulation of SMT3A gene expression in association with DNA synthesis induction after X-ray irradiation in nevoid basal cell carcinoma syndrome (NBCCS) cells. Mutat Res (2005) 0.78
Proteolytic degradation of glutamate decarboxylase mediates disinhibition of hippocampal CA3 pyramidal cells in cathepsin D-deficient mice. J Neurochem (2005) 0.78
Absorption of lithium in montmorillonite: a density functional theory (DFT) study. J Nanosci Nanotechnol (2011) 0.78
Ultrastructural localization of cochlin in the rat cochlear duct. Audiol Neurootol (2009) 0.78
KR-003048, a potent, orally active inhibitor of p38 mitogen-activated protein kinase. Eur J Pharmacol (2010) 0.78
Activation of mu-calpain in developing cortical neurons following methylmercury treatment. Brain Res Dev Brain Res (2003) 0.78
Congenital middle ear cholesteatoma: experience from 26 surgical cases. Ann Otol Rhinol Laryngol (2013) 0.78
Specific localization of five phosphatidylcholine species in the cochlea by mass microscopy. Audiol Neurootol (2010) 0.78
Application of ultra-high magnetic field for saccharide molecules: 1H NMR spectra of 6-O-alpha-D-glucopyranosyl-cyclomaltoheptaose and -cyclomaltohexaose. Carbohydr Res (2005) 0.78
Synthesis and conformational properties of phosphopeptides related to the human tau protein. Regul Pept (2005) 0.78
Sibutramine induces potential-dependent exocytotic release but not carrier-mediated release of dopamine and 5-hydroxytryptamine. Eur J Pharmacol (2004) 0.78
Age-Related and Degenerative Changes in the Osseous Anatomy, Alignment, and Range of Motion of the Cervical Spine: A Comparative Study of Radiographic Data From 1016 Patients With Cervical Spondylotic Myelopathy and 1230 Asymptomatic Subjects. Spine (Phila Pa 1976) (2016) 0.77
Phosphorylation modulates the local conformation and self-aggregation ability of a peptide from the fourth tau microtubule-binding repeat. FEBS J (2007) 0.77
Phospholipids modulate superoxide and nitric oxide production by lipopolysaccharide and phorbol 12-myristate-13-acetate-activated microglia. Neurochem Int (2006) 0.77
Phosphatidylserine-containing liposomes: potential pharmacological interventions against inflammatory and immune diseases through the production of prostaglandin E(2) after uptake by myeloid derived phagocytes. Arch Immunol Ther Exp (Warsz) (2011) 0.77
Low-barrier hydrogen bond between phosphate and the amide group in phosphopeptide. J Am Chem Soc (2005) 0.77
2,5-Diaminopyrimidines and 3,5-disubstituted azapurines as inhibitors of glycogen synthase kinase-3 (GSK-3). Bioorg Med Chem Lett (2008) 0.77
Pattern recognition analysis for classification of hypertensive model rats and diurnal variation using 1H-NMR spectroscopy of urine. Anal Sci (2005) 0.77
[Synaptic plasticity and synaptic reorganization regulated by microglia]. Nihon Shinkei Seishin Yakurigaku Zasshi (2013) 0.76
Possible involvement of aiPLA2 in the phosphatidylserine-containing liposomes induced production of PGE2 and PGD2 in microglia. J Neuroimmunol (2013) 0.76
pH-dependent aggregate forms and conformation of Alzheimer amyloid beta-peptide (12-24). J Biochem (2002) 0.76
'Reverse' alpha-ketoamide-based p38 MAP kinase inhibitors. Bioorg Med Chem Lett (2008) 0.76